Related Experiment Videos
[Cyclin D1 overexpression in laryngeal carcinomas]
X F Wang1, T Nakashima, M Masuda
1Department of Otorhinolaryngology, Faculty of Medicine, Kyushu University, Fukuoka.
Nihon Jibiinkoka Gakkai Kaiho
|April 18, 1998
Summary
Overexpression of cyclin D1 protein was found in 30.4% of laryngeal carcinomas. Cyclin D1 overexpression may predict tumor recurrence, aiding in early detection for better patient outcomes.
Area of Science:
- Oncology
- Molecular Biology
- Pathology
Context:
- Cyclin D1 overexpression is implicated in various cancers and tumor progression.
- Laryngeal carcinoma is a significant global health concern.
- Understanding molecular markers is crucial for cancer management.
Purpose:
- To investigate the prevalence of cyclin D1 protein overexpression in laryngeal carcinomas.
- To determine the correlation between cyclin D1 overexpression and clinicopathological features of laryngeal cancer.
- To evaluate cyclin D1 as a potential predictive marker for laryngeal tumor recurrence.
Summary:
- Immunohistochemical analysis of 92 laryngeal carcinoma specimens revealed cyclin D1 overexpression in 30.4% of cases.
- No significant association was found between cyclin D1 overexpression and tumor stage, lymph node metastasis, or overall clinical outcome.
- A significantly higher rate of cyclin D1 overexpression was observed in patients experiencing local recurrence compared to those without recurrence.
Impact:
- Cyclin D1 immunohistochemical staining emerges as a potentially valuable biomarker for predicting the risk of laryngeal carcinoma recurrence.
- This finding could guide clinical decisions regarding patient monitoring and adjuvant therapies.
- Further research can explore therapeutic strategies targeting cyclin D1 in laryngeal cancer.